Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
fidaxomicin
Tillotts Pharma GmbH
A07AA12
fidaxomicin
Antidiarrheals, intestinal antiinflammatory / antiinfective agents
Clostridium Infections
Dificlir film-coated tablets is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12.5 kg.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.Dificlir granules for oral suspension is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adults and paediatric patients from birth to < 18 years of age.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.
Revision: 17
Authorised
2011-12-05
32 B. PACKAGE LEAFLET 33 PACKAGE LEAFLET: INFORMATION FOR THE USER DIFICLIR 200 MG FILM-COATED TABLETS fidaxomicin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What DIFICLIR is and what it is used for 2. What you need to know before you take DIFICLIR 3. How to take DIFICLIR 4. Possible side effects 5. How to store DIFICLIR 6. Contents of the pack and other information 1. WHAT DIFICLIR IS AND WHAT IT IS USED FOR DIFICLIR is an antibiotic which contains the active substance fidaxomicin. DIFICLIR film-coated tablets are used in adults, adolescents and children with a body weight of at least 12.5 kg to treat infections of the lining of the colon (large intestine) with certain bacteria called _Clostridioides difficile_ . This serious illness can result in painful, severe diarrhoea. DIFICLIR works by killing the bacteria that cause the infection and helps to reduce the associated diarrhoea. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DIFICLIR DO NOT TAKE DIFICLIR − If you are allergic to fidaxomicin or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking DIFICLIR. If you feel that you might have a severe allergic reaction such as trouble breathing (dyspnea), swelling of the face or throat (angioedema), severe rash, severe itching (pruritus) or severe hives (urticaria), stop taking DIFICLIR and seek medical advice urgently from your doctor, pharmacist or at your local hospital emergency department (see section Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT DIFICLIR 200 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 200 mg of fidaxomicin. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Capsule shaped tablets of 14 mm, white to off-white in colour, debossed with “FDX” on one side and “200” on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS DIFICLIR film-coated tablets is indicated for the treatment of _Clostridioides difficile_ infections (CDI) also known as _C. difficile_ -associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12.5 kg (see section 4.2 and 5.1). Consideration should be given to official guidelines on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults _ Standard dosing _ _ The recommended dose is 200 mg (one tablet) administered twice daily (once every 12 hours) for 10 days (see section 5.1). DIFICLIR 40 mg/ml granules for oral suspension may be used in adult patients with difficulties in swallowing tablets. Extended-pulsed dosing Fidaxomicin 200 mg tablets administered twice daily for days 1-5 (no intake of a tablet on day 6) then once daily on alternate days for days 7-25 (see section 5.1). If a dose has been forgotten, the missed dose should be taken as soon as possible or, if it's nearly time for the next dose, the tablet should be skipped altogether. Special populations _Elderly population _ No dose adjustment is considered necessary (see section 5.2). _Renal impairment _ No dose adjustment is considered necessary. Due to the limited clinical data in this population, fidaxomicin should be used with caution in patients with severe renal impairment (see sections 4.4 and 3 5.2). _Hepatic impairment _ No dose adjustment is considered necessary. Due to the limited clinical data in this population, fidaxomicin should be used with caution in patients with moderat Przeczytaj cały dokument